Use of the oral beta blocker bisoprolol to reduce the rate of exacerbation in people with chronic obstructive pulmonary disease (COPD): a randomised controlled trial. (BICS)

Seonaidh Cotton, Graham Devereux* (Corresponding Author), Hassan Abbas, Andrew H Briggs, Karen Campbell, Rekha Chaudhuri, Gourab Choudhury, Dana Dawson, Anthony De Soyza, Shona Fielding, Simon Gompertz, John Haughney, Chim C Lang, Amanda Lee, Graeme MacLennan, William MacNee, Kirsty McCormack, Nicola McMeekin, Nicholas L Mills, Alyn MoriceJohn Norrie, Linda Petrie, David Price, Philip Short, Jørgen Vestbo, Paul Walker, Jadwiga A Wedzicha, Andrew Wilson, Brian J Lipworth

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

4 Citations (Scopus)
2 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Use of the oral beta blocker bisoprolol to reduce the rate of exacerbation in people with chronic obstructive pulmonary disease (COPD): a randomised controlled trial. (BICS)'. Together they form a unique fingerprint.

Medicine & Life Sciences